Docket #: S01-245G
Anti-Pknox monoclonal antibody
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pknox monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis. The Meis/Pknox (also known as Prep) subfamily of TALE (three-amino acid loop extension)-class homeodomian proteins heterodimerze with Pbx proteins to form trimeric complexes with Hox proteins on appropriate DNA sites that regulate developmental gene expression. The anti-Pknox antibodies could be used in research related to leukemia, embryonic development, and tissue homeostasis.
Applications
- Research related to:
- leukemia
- embryonic development
- tissue homeostasis
Publications
- Jacobs Y, Schnabel CA, Cleary ML., "Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity." Mol Cell Biol. 1999 Jul;19(7):5134-42.
Web Site
Similar Technologies
-
Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7 S83-007Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7
-
Hermes-1, and -3, and other Monoclonal Antibodies to Human CD44 S95-023Hermes-1, and -3, and other Monoclonal Antibodies to Human CD44
-
Anti-Pbx1a monoclonal antibody S01-245AAnti-Pbx1a monoclonal antibody